Compared to Distribution

an indicator guage with the arrow in the green the value is in the best half of communities.

an indicator guage with the arrow in the yellow the value is in the 2nd worst quarter of communities.

an indicator guage with the arrow in the red the value is in the worst quarter of communities.

Compared to Target

green circle with white tick inside it meets target; red circle with white cross inside it does not meet target.

Compared to a Single Value

green diamond with downward arrow inside it lower than the comparison value; red diamond with downward arrow inside it higher than the comparison value; blue diamond with downward arrow inside it not statistically different from comparison value.

Trend

green square outline with upward trending arrow inside it green square outline with downward trending arrow inside it non-significant change over time; green square with upward trending arrow inside it green square with downward trending arrow inside it significant change over time; blue square with equals sign no change over time.

Compared to Prior Value

green triangle with upward trending arrow inside it higher than the previous measurement period; green triangle with downward trending arrow inside it lower than the previous measurement period; blue equals sign no statistically different change from previous measurement period.

green chart bars Significantly better than the overall value

red chart bars Significantly worse than the overall value

light blue chart bars No significant difference with the overall value

gray chart bars No data on significance available

Prostate-Specific Antigen Test History

Measurement Period: 2016

This indicator shows the percentage of men over 50 who have received a prostate-specific antigen (PSA) test in the past two years.

Why is this important?

A Prostate-Specific Antigen (PSA) test measures the levels in the blood of prostate-specific antigen, a protein produced by the prostate. The level of PSA in the blood can be increased by prostate cancer or inflammation of the prostate gland. The National Cancer Institute recommends the use of a PSA test along with a digital rectal exam to help detect prostate cancer in men 50 years of age or older. Early detection may prevent some of the associated health problems and reduce the risk of dying from the cancer. Prostate cancer is second only to lung cancer as a cause of cancer-related death among men. PSA tests are also used to monitor men with a history of prostate cancer for recurrence.

More...

County: Miami-Dade

49.4%

Source: Florida Behavioral Risk Factor Surveillance System
Measurement period: 2016
Maintained by: Conduent Healthy Communities Institute
Last update: April 2018

Compared to See the Legend